drugset / Trial / NCT01437839

Food Effect Study For Apixaban Commercial Image Tablets

NCT01437839

Phase 1 Completed 22 enrolled Pfizer
RandomizedCrossoverOpen-labelTreatment

Summary

To evaluate the effect of food on the pharmacokinetics of apixaban administered as commercial image tablets.

Timeline

Start
2011-09
Primary completion
2011-10
Completion
2011-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Apixaban Small molecule 5 mg Oral

Indications

No indication recorded.